WESAIL New Crown Antigen Self-Test Kit Obtain CE0123 Self-Test Certificate
On May 31, 2021, the novel coronavirus (COVID-19) antigen self-test kit (hereinafter referred to as "WESAIL new crown antigen self-test kit") developed and produced by Guangdong Weishi Biotechnology Co., Ltd. (hereinafter referred to as "WESAIL") won the CE0123 self-test certificate issued by the world-renowned TÜV SÜD (hereinafter referred to as "TÜV SÜD"), helping WESAIL to accelerate its entry into overseas markets.
Prior to this, the WESAIL new crown antigen self-test kit has successfully passed the German PEI certification, and has been approved to enter the BfArM white list of the German Federal Drug and Medical Device Agency and the ANSM white list of the French Food and Drug Administration Home Antigen Test Kit. This time, it has been certified by TÜV SÜD and issued a CE0123 self-test certificate, which means that the excellent performance of the WESAIL new crown antigen self-test kit has been fully recognized by the industry and international authority can be free circulation.
The WESAIL new crown antigen self-test kit has stable performance and can quickly, sensitively and conveniently complete the screening and diagnosis of infected people. The reagent is detected by nasal swab, and the result can be obtained in 15 minutes. Local citizens can buy the product through supermarkets or pharmacies for home self-testing, which better meets the needs of large-scale population rapid testing, which will provide strong help for overseas epidemic prevention and control, resumption of work and production.